Particle.news

Download on the App Store

Germany’s New Drug Commissioner Flags Opioid Threat and Pushes for Evidence-Based Reforms

A virologist by training, Streeck is bringing a medical perspective to shape drug policy.

Hendrik Streeck
Image
Hendrick Streeck

Overview

  • Streeck warned that Germany still has time to avert an opioid crisis like the one in the US and will develop a cross-ministry package of stronger police work, prevention campaigns and enhanced addiction care.
  • He plans to involve parents, police, educators and medical experts in a scientific review of cannabis legalization, with decisions deferred until an evaluation study due this autumn.
  • Citing DAK figures showing 1.3 million youths at risk of digital addiction, he will collaborate with health and education ministries to launch media-use prevention initiatives.
  • Emphasizing that nearly ten million Germans live with addiction, he redefined drug policy as a public health priority rather than an ideological battleground.
  • Drawing on his COVID-19 research background, Streeck rejects ideological approaches and insists on evidence-based analysis to guide national drug strategy.